News and Insights of 3D Printing and Manufacturing
Researchers at the University of Sydney have developed 3D printed blood vessels on glass that replicate both the anatomy and fluid dynamics of real arteries. Published in Advanced Materials, the technology provides a new platform to study stroke mechanisms and test patient-specific medications.
US-based Boise State University researchers are developing a first-of-its-kind 3D printed device aimed at improving the accuracy of biomechanical testing in Boise, Idaho. Supported by the TRANSFORM Seed Grants Program part of the National Science Foundation’s ART award, the team plans to launch the tool commercially next year, advancing the translation of university research into real-world applications.
Researchers at Texas A&M University are developing a 3D printing approach to tackle a long-standing gap in pediatric care: the lack of safe, precisely measured drug doses for children. Led by Professor Mansoor Khan, the team is building hospital-ready technology designed to replace improvised liquid formulations with on-demand, accurately dosed tablets — a shift that is expected to improve treatment consistency and patient outcomes.
Alquist, a 3D construction printing (3DCP) company, has partnered with Walmart and other commercial retailers to deliver more than a dozen construction projects across the United States, marking the largest-scale deployment of 3D printed commercial building technology in US history.
Ceramic 3D printing specialist Lithoz is using this year’s formnext to demonstrate that ceramic 3D printing has firmly entered industrial-scale production. The company’s Booth 11.1 C35 centers on real-world applications manufactured with its LCM technology across aerospace, semiconductors, medical devices and high-end consumer goods, underscoring how ceramic additive manufacturing (AM) is now being adopted in serial production environments.
Researchers at Swiss Federal Institute of Technology in Zurich. (ETH Zurich) have successfully 3D printed human muscle tissue in microgravity during parabolic flight experiments, marking a milestone in space-based biofabrication. The study aims to enhance disease modeling and drug development by recreating human tissues under gravity-free conditions that more accurately reflect the body’s natural architecture.
Tiger Aesthetics Medical, a division of Tiger Biosciences based in Conshohocken, Pennsylvania, has announced a strategic investment in GenesisTissue Inc, an early-stage biotechnology company developing personalized 3D bioprinting technologies for breast reconstruction and cosmetic surgery. The startup is creating solutions for both lumpectomy and mastectomy reconstruction, as well as aesthetic applications. This collaboration extends Tiger Biosciences’ regenerative medicine initiatives and follows the 2025 launch of alloClae, a ready-to-use structural adipose tissue product for body contouring.
Researchers at University of New South Wales Canberra, a campus of the University of New South Wales (UNSW Sydney), have developed a new type of 3D printed, biodegradable bone implant that closely mimics the internal structure of natural bone. The innovation could improve recovery for patients with fractures or bone injuries by enabling customized implants that dissolve naturally after healing, eliminating the need for additional surgery.
The town of Holstebro in Denmark just got a new landmark: Europe’s largest 3D printed housing project. The ambitious build, called Skovsporet (“The Forest Trail”), will ultimately consist of 36 student apartments, whose walls are made using COBOD’s BOD3 construction 3D printer. The project has just completed its 3D printing phase and is now preparing to move into the interior construction phase.
Researchers at the McGill University, supported by funding from the National Institutes of Health (NIH), have created what is being called the smallest bioprinter reported to date—just 2.7 mm wide—that can accurately deliver hydrogels to vocal cords during surgery, helping prevent post-operative stiffness and improve patients’ ability to speak. The study was published in Cell Press journal Device.